The data likely indicates that the spleen is a sink for anti-TIGIT antibody, and blocking of TIGIT antigen in the spleen increases 89Zr-αTIGIT in circulation, allowing for the tracer to reach and accumulate within the tumor. The gene discussed is TIGIT; the disease is neoplasm.